Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair [bulkRNA-seq]

ABSTRACT: Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair [bulkRNA-seq]

PROVIDER: PRJNA1273019 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR33855800_1.fastq.gz	Fastqsanger.gz
	SRR33855800_2.fastq.gz	Fastqsanger.gz
	SRR33855801_1.fastq.gz	Fastqsanger.gz
	SRR33855801_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 95

Similar Datasets

Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair [bulkRNA-seq]

Project description:Human pluripotent stem cell (hPSC)-derived cardiac therapies hold great promise for heart 41 regeneration but face major translational barriers due to allogeneic immune rejection. Here, we 42 engineered hypoimmunogenic hPSCs using a two-step CRISPR-Cas9 strategy: (1) B2M 43 knockout, eliminating HLA class I surface expression, and (2) knock-in of HLA-E or HLA-G trimer 44 constructs in the AAVS1 safe harbor locus to confer robust immune evasion. Hypoimmunogenic 45 hPSCs maintained pluripotency, efficiently differentiated into cardiac cell types that resisted both 46 T and NK cell-mediated cytotoxicity in vitro, and self-assembled into engineered cardiac 47 organoids. Comprehensive analyses of the hypoimmunogenic cells and organoids revealed 48 preservation of transcriptomic, structural, and functional properties with minimal off-target effects 49 from gene editing. In vivo, hypoimmunogenic cardiac organoids restored contractile function in 50 infarcted rat hearts and demonstrated superior graft retention and immune evasion in humanized 51 mice compared to wild-type counterparts. These findings establish the therapeutic potential of 52 hypoimmunogenic hPSC-CMs in the cardiac organoid platform, laying the foundation for off-the shelf cardiac cell therapies to treat cardiovascular disease, the leading cause of death worldwide.

2025-06-08 | GSE299171 | GEO

Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair [scRNA-seq]

2025-06-08 | GSE299172 | GEO

Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair [scRNA-seq]

Project description:Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair [scRNA-seq]

| PRJNA1273020 | ENA

Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance [bulkRNA-Seq]

Project description:Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance [bulkRNA-Seq]

| PRJNA686966 | ENA

Heart Repair with Engineered Heart Muscle

Project description:Heart Repair with Engineered Heart Muscle

| PRJNA1154291 | ENA

Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance [bulkRNA-Seq]

Project description:Heart disease can be caused by ischemic coronary artery injury, hypertension, and chemotherapy, all of which lead to loss or dysfunction of cardiac muscle. The adult mammalian heart lacks the ability to regenerate. In contrast, the heart of neonatal mice, within the first week after birth, possesses a unique ability to regenerate lost myocardium following injury, mediated by proliferation of cardiomyocytes. The mechanisms whereby neonatal cardiomyocytes adapt to injury-induced stress conditions and activate regenerative cellular programs remain to be defined. Here, we show that Nrf1, an endoplasmic reticulum (ER) bound transcription factor, is expressed in regenerating cardiomyocytes. Genetic deletion of Nrf1 prevented cardiomyocytes from activating a transcriptional program required for heart regeneration, revealed by single-nucleus RNA sequencing (snRNA-seq). Conversely, adeno-associated virial (AAV) overexpression of Nrf1 protected the adult mouse heart from ischemia/reperfusion (I/R) injury. Nrf1 also protected human induced pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) from doxorubicin-induced cardiotoxicity. The protective function of Nrf1 is mediated by a dual stress response mechanism involving activation of the proteasome and redox balance. Our findings reveal a mechanistic interplay between adaptive stress responses and heart regeneration, and highlight the central role of Nrf1 in these processes.

2021-05-01 | GSE163628 | GEO

RNA seq for Rat's heart infarction

Project description:This project performed BulkRNA sequencing on the myocardial tissue of rats one month after myocardial infarction and attempted to reveal the transcriptome differences in the myocardial infarction area of rats among different groups.

2024-01-10 | GSE252825 | GEO

Single-cell RNA sequencing of hPSC-derived endothelial-to-haematopoietic transition

Project description:scRNAseq of sequential time points and CDKi-treated samples during endothelial-to-haematopoietic transition in cells derived by hPSC differentiation.

2020-07-31 | E-MTAB-8205 | biostudies-arrayexpress

EMSY inhibits homologous recombination repair and the interferon response promoting lung cancer immune evasion

Project description:EMSY inhibits homologous recombination repair and the interferon response promoting lung cancer immune evasion

| PRJNA692239 | ENA

EMSY inhibits homologous recombination repair and the interferon response promoting lung cancer immune evasion

Project description:EMSY inhibits homologous recombination repair and the interferon response promoting lung cancer immune evasion

| PRJNA739447 | ENA